Astrocytic Ca2+ activation by chemogenetics mitigates the effect of kainic acid-induced excitotoxicity on the hippocampus
- PMID: 39188024
- DOI: 10.1002/glia.24607
Astrocytic Ca2+ activation by chemogenetics mitigates the effect of kainic acid-induced excitotoxicity on the hippocampus
Abstract
Astrocytes play a multifaceted role regulating brain glucose metabolism, ion homeostasis, neurotransmitters clearance, and water dynamics being essential in supporting synaptic function. Under different pathological conditions such as brain stroke, epilepsy, and neurodegenerative disorders, excitotoxicity plays a crucial role, however, the contribution of astrocytic activity in protecting neurons from excitotoxicity-induced damage is yet to be fully understood. In this work, we evaluated the effect of astrocytic activation by Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) on brain glucose metabolism in wild-type (WT) mice, and we investigated the effects of sustained astrocyte activation following an insult induced by intrahippocampal (iHPC) kainic acid (KA) injection using 2-deoxy-2-[18F]-fluoro-D-glucose (18F-FDG) positron emission tomography (PET) imaging, along with behavioral test, nuclear magnetic resonance (NMR) spectroscopy and histochemistry. Astrocytic Ca2+ activation increased the 18F-FDG uptake, but this effect was not found when the study was performed in knock out mice for type-2 inositol 1,4,5-trisphosphate receptor (Ip3r2-/-) nor in floxed mice to abolish glucose transporter 1 (GLUT1) expression in hippocampal astrocytes (GLUT1ΔGFAP). Sustained astrocyte activation after KA injection reversed the brain glucose hypometabolism, restored hippocampal function, prevented neuronal death, and increased hippocampal GABA levels. The findings of our study indicate that astrocytic GLUT1 function is crucial for regulating brain glucose metabolism. Astrocytic Ca2+ activation has been shown to promote adaptive changes that significantly contribute to mitigating the effects of KA-induced damage. This evidence suggests a protective role of activated astrocytes against KA-induced excitotoxicity.
Keywords: DREADDs; FDG PET; astrocyte; excitotoxicity; metabolism.
© 2024 The Author(s). GLIA published by Wiley Periodicals LLC.
References
REFERENCES
-
- Adamsky, A., Kol, A., Kreisel, T., Doron, A., Ozeri‐Engelhard, N., Melcer, T., Refaeli, R., Horn, H., Regev, L., Groysman, M., London, M., & Goshen, I. (2018). Astrocytic activation generates De novo neuronal potentiation and memory enhancement. Cell, 174, 59–71.e14. https://doi.org/10.1016/j.cell.2018.05.002
-
- Al Sufiani, F., & Ang, L. C. (2012). Neuropathology of temporal lobe epilepsy. Epilepsy Research and Treatment, 2012, 624519. https://doi.org/10.1155/2012/624519
-
- Alami, N. O., Tang, L., Wiesner, D., Commisso, B., Bayer, D., Weishaupt, J., Dupuis, L., Wong, P., Baumann, B., Wirth, T., Boeckers, T. M., Yilmazer‐Hanke, D., Ludolph, A., & Roselli, F. (2020). Multiplexed chemogenetics in astrocytes and motoneurons restore blood‐spinal cord barrier in ALS. Life Science Alliance, 3, 1–28.
-
- Alcaraz, F., Fresno, V., Marchand, A. R., Kremer, E. J., Coutureau, E., & Wolff, M. (2018). Thalamocortical and corticothalamic pathways differentially contribute to goal‐directed behaviors in the rat. eLife, 7, e32517. https://doi.org/10.7554/eLife.32517
-
- Andersen, J. V., Markussen, K. H., Jakobsen, E., Schousboe, A., Waagepetersen, H. S., Rosenberg, P. A., & Aldana, B. I. (2021). Glutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration. Neuropharmacology, 196, 108719. https://doi.org/10.1016/j.neuropharm.2021.108719
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous